Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
Josep M. Llovet(Icahn School of Medicine at Mount Sinai), Peiguo Cao(Central South University), Philippe Merle(Hôpital de la Croix-Rousse), Ho Yeong Lim(CHA University Bundang Medical Center), В. В. Бредер, Ann‐Lii Cheng(National Taiwan University), Luis J. Villanueva-Rivera, Masafumi Ikeda(National Cancer Center Hospital East), Janine M. Davies(Australian Wildlife Conservancy), Vladimir Andelkovic, Zhenggang Ren(Ministry of Education of the People's Republic of China), Masatoshi Kudo(Kindai University), Baek‐Yeol Ryoo(Asan Medical Center), Corina E. Dutcus(Eisai (United States)), Gianluca Masi(University of Pisa), Tim Meyer(The Royal Free Hospital), Mayur Brahmania, Jamil Asselah, Marcelo Garrido(Pontificia Universidad Católica de Chile), William Sievert(Monash Health), Jennifer J. Knox(National Cancer Center), Shuichi Kaneko(Kanazawa University), Peter R. Galle(Johannes Gutenberg University Mainz), Julien Edeline(Inserm), Aflah Roohullah, Richard S. Finn(University of California, Los Angeles), Kalgi Mody(Eisai (United States)), Shukui Qin(Memorial Sloan Kettering Cancer Center), Alexander Thompson(University of Manchester), Leonid Dubrovsky(Merck & Co., Inc., Rahway, NJ, USA (United States)), Simone I. Strasser(University of Padua), Chunyi Hao(Peking University), Hongming Pan, Xi Chen(National Taiwan University Hospital), Tao Zhang(Fudan University), Anran Wang(Zhejiang University), Jee Hyun Kim(Korea University), Kangsheng Gu(Anhui Medical University), Mariusz Kwiatkowski, Gonzalo Pizarro, Nicolás Yáñez, Hiromitsu Kumada(Toranomon Hospital), Habeeb Majeed(Princess Margaret Cancer Centre), Shuangyan Ou, Abby B. Siegel(Merck & Co., Inc., Rahway, NJ, USA (United States)), Zhiqiang Meng(Fudan University Shanghai Cancer Center), Ruocai Xu(Hunan Cancer Hospital), Patricio Yañez Weber(Universidad de La Frontera)
Cited by 436
Related Papers
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
|Journal of Hepatology|2001|4.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2016|2.7k
Simplified criteria for the diagnosis of autoimmune hepatitis†
|Hepatology|2008|1.9k
Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma
|JNCI Journal of the National Cancer Institute|2008|1.7k